All Stories

  1. Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer

    Article • Expert Opinion on Investigational Drugs, July 2019, Taylor & Francis

    Dr Federica Tomao

  2. The impact of CO2 laser for treatment of Bartholin’s gland cyst or abscess on female sexual function: a pilot study

    Article • Gynecological Endocrinology, August 2018, Taylor & Francis

    Dr Federica Tomao

  3. Triple-negative breast cancer: new perspectives for targeted therapies

    Article • OncoTargets and Therapy, January 2015, Taylor & Francis

    Dr Federica Tomao, Dr Anselmo Papa

  4. Angiogenesis and antiangiogenic agents in cervical cancer

    Article • OncoTargets and Therapy, December 2014, Taylor & Francis

    Dr Federica Tomao, Dr Anselmo Papa

  5. Cervical Cancer: Are There Potential New Targets? An Update on Preclinical and Clinical Results

    Article • Current Drug Targets, November 2014, Bentham Science Publishers

    Dr Federica Tomao

  6. Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review

    Article • OncoTargets and Therapy, July 2014, Taylor & Francis

    Dr Federica Tomao, Dr Roberta Iadarola

  7. Correlation between fertility drugs use and malignant melanoma incidence: the state of the art

    Article • Tumor Biology, June 2014, Springer Science + Business Media

    Dr Federica Tomao

  8. Clinical use of fertility agents and risk of breast cancer

    Article • Current Opinion in Obstetrics & Gynecology, June 2014, Wolters Kluwer Health

    Dr Federica Tomao

  9. Benign schwannoma in supraclavicular region: a false-positive lymph node recurrence of breast cancer suspected by PET scan

    Article • Archives of Gynecology and Obstetrics, April 2014, Springer Science + Business Media

    Dr Federica Tomao

  10. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis

    Article • Tumor Biology, March 2014, Springer Science + Business Media

    Dr Federica Tomao

  11. Immunologic treatments for precancerous lesions and uterine cervical cancer

    Article • Journal of Experimental & Clinical Cancer Research, March 2014, Springer Science + Business Media

    Dr Federica Tomao

  12. Investigating Molecular Profiles of Ovarian Cancer: An Update on Cancer Stem Cells

    Article • Journal of Cancer, January 2014, Ivyspring International Publisher

    Dr Federica Tomao

  13. Emerging Biological Treatments for Uterine Cervical Carcinoma

    Article • Journal of Cancer, January 2014, Ivyspring International Publisher

    Dr Federica Tomao

  14. Fertility drugs, reproductive strategies and ovarian cancer risk

    Article • Journal of Ovarian Research, January 2014, Springer Science + Business Media

    Dr Federica Tomao

  15. Modified gluteal fold advancement V-Y flap for vulvar reconstruction after surgery for vulvar malignancies

    Article • Gynecologic Oncology, January 2014, Elsevier

    Dr Federica Tomao

  16. Impaired uterine artery flow associated with the presence of ovarian endometrioma: preliminary results of a prospective study

    Article • Journal of Ovarian Research, January 2014, Springer Science + Business Media

    Dr Federica Tomao

  17. Non-Pegylated Liposomal Doxorubicin-Cyclophosphamide in Sequential Regimens with Taxanes as Neoadjuvant Chemotherapy in Breast Cancer Patients

    Article • Journal of Cancer, January 2014, Ivyspring International Publisher

    Dr Federica Tomao

  18. Hot flushes in women with breast cancer: state of the art and future perspectives

    Article • Expert Review of Anticancer Therapy, December 2013, Taylor & Francis

    Dr Federica Tomao

  19. Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

    Article • Therapeutics and Clinical Risk Management, November 2013, Taylor & Francis

    Dr Federica Tomao, Dr Edoardo Francini, Dr Anselmo Papa

  20. Breast adenomyoepithelioma: a case report with malignant proliferation of epithelial and myoepithelial elements

    Article • World Journal of Surgical Oncology, October 2013, Springer Science + Business Media

    Dr Federica Tomao

  21. Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer

    Article • Expert Opinion on Investigational Drugs, October 2013, Informa Healthcare

    Dr Federica Tomao

  22. Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients

    Article • Journal of Experimental & Clinical Cancer Research, August 2013, Springer Science + Business Media

    Dr Federica Tomao

  23. Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach

    Article • Journal of Experimental & Clinical Cancer Research, August 2013, Springer Science + Business Media

    Dr Federica Tomao

  24. Thyroid dysfunction and tyrosine kinase inhibitors in renal cell carcinoma

    Article • July 2013, Bioscientifica

    Dr Federica Tomao

  25. Current status of bevacizumab in advanced ovarian cancer

    Article • OncoTargets and Therapy, July 2013, Taylor & Francis

    Dr Federica Tomao, Dr Davide Caruso, Dr Anselmo Papa

  26. A 68-year-old Caucasian man presenting with urinary bladder lymphoepithelioma: a case report

    Article • Journal of Medical Case Reports, June 2013, Springer Science + Business Media

    Dr Federica Tomao

  27. Breast cancer risk after exposure to fertility drugs

    Article • Expert Review of Anticancer Therapy, February 2013, Taylor & Francis

    Dr Federica Tomao

  28. An Update of Laparoscopy in Cervical Cancer Staging: Is It a Useful Procedure?

    Article • Oncology, January 2013, Karger Publishers

    Dr Federica Tomao

  29. Tumor-derived microvesicles: The metastasomes

    Article • Medical Hypotheses, January 2013, Elsevier

    Dr Federica Tomao

  30. Improvement in Progression-Free Survival in OCEANS Bevacizumab Arm: A Critical Point of View

    Article • Journal of Clinical Oncology, November 2012, American Society of Clinical Oncology (ASCO)

    Dr Federica Tomao

  31. M372 INCIDENCE OF AMENORRHEA IN PREMENOPAUSAL WOMEN WITH BREAST CANCER (BC) UNDERGOING CHEMOTHERAPY (CT) WITH ANTHRACYCLINE (A), CYCLOPHOSPHAMIDE (C) AND DOCETAXEL (T)

    Article • International Journal of Gynecology & Obstetrics, October 2012, Wiley

    Dr Federica Tomao

  32. Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer

    Article • OncoTargets and Therapy, September 2012, Taylor & Francis

    Dr Federica Tomao, Dr Angelo Zullo, Dr Anselmo Papa

  33. Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

    Article • Future Oncology, September 2012, Future Medicine

    Dr Federica Tomao

  34. Breast cancer metastatic to the pituitary gland: a case report

    Article • World Journal of Surgical Oncology, July 2012, Springer Science + Business Media

    Dr Federica Tomao

  35. Current knowledge and open issues regarding Bevacizumab in gynaecological neoplasms

    Article • Critical Reviews in Oncology/Hematology, July 2012, Elsevier

    Dr Federica Tomao

  36. Intraperitoneal Chemotherapy by Ultrasound-Guided Direct Puncture in Recurrent Ovarian Cancer: Feasibility, Compliance, and Complications

    Article • International Journal of Gynecological Cancer, July 2012, BMJ

    Dr Federica Tomao

  37. Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases

    Article • Oncology Reviews, June 2012, PAGEPress Publications

    Dr Federica Tomao

  38. Gonadotropin-Releasing Hormone Agonists for the Preservation of Ovarian Function During Chemotherapy

    Article • Journal of Clinical Oncology, May 2012, American Society of Clinical Oncology (ASCO)

    Dr Federica Tomao

  39. Role of chemotherapy in the management of vulvar carcinoma

    Article • Critical Reviews in Oncology/Hematology, April 2012, Elsevier

    Dr Federica Tomao

  40. Current role and safety profile of aromatase inhibitors in early breast cancer

    Article • Expert Review of Anticancer Therapy, August 2011, Taylor & Francis

    Dr Federica Tomao

  41. Epistaxis in Weekly Paclitaxel Regimen: Is it Really Related to Schedule?

    Article • Basic & Clinical Pharmacology & Toxicology, November 2010, Wiley

    Dr Federica Tomao

  42. Ovarian function, reproduction and strategies for fertility preservation after breast cancer

    Article • Critical Reviews in Oncology/Hematology, October 2010, Elsevier

    Dr Federica Tomao

  43. Phase I–II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines

    Article • Cancer Chemotherapy and Pharmacology, May 2010, Springer Science + Business Media

    Dr Federica Tomao

  44. Emerging role of pemetrexed in ovarian cancer

    Article • Expert Review of Anticancer Therapy, December 2009, Taylor & Francis

    Dr Federica Tomao

  45. Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer

    Article • International Journal of Nanomedicine, April 2009, Taylor & Francis

    Dr Federica Tomao

  46. The synchronous occurrence of squamous cell carcinoma and gastrointestinal stromal tumor (GIST) at esophageal site

    Article • World Journal of Surgical Oncology, November 2008, Springer Science + Business Media

    Dr Federica Tomao

  47. Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)

    Article • Journal of Experimental & Clinical Cancer Research, October 2008, Springer Science + Business Media

    Dr Federica Tomao

  48. MAGE-A and NY-ESO-1 expression in cervical cancer: Prognostic factors and effects of chemotherapy

    Article • American Journal of Obstetrics and Gynecology, January 2008, Elsevier

    Dr Federica Tomao

  49. Late Breast Cancer Recurrence to the Uterine Cervix With a Review of the Literature

    Article • International Journal of Gynecological Pathology, January 2008, Wolters Kluwer Health

    Dr Federica Tomao

  50. A Comparative Analysis of Serum and Serum-free Media for Generation of Clinical Grade DCs

    Article • Journal of Immunotherapy, July 2007, Wolters Kluwer Health

    Dr Federica Tomao

  51. Metastatic infiltration of adenocarcinoma of the rectum in hard palate: Report of a case and a review of the literature

    Article • Oral Oncology Extra, May 2006, Elsevier

    Dr Federica Tomao